Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
about
Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of LiteratureChemotherapy-induced peripheral neuropathy: A current review.Dose considerations for anti-cancer drugs in metastatic prostate cancer.The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer.Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer.
P2860
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
@en
type
label
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
@en
prefLabel
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
@en
P2093
P2860
P50
P1433
P1476
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
@en
P2093
Angela Gernone
Caterina Messina
Davide Bosso
Davide Dondi
Donatello Gasparro
Giuseppe Di Lorenzo
Guru Sonpavde
Livio Puglia
Sabino De Placido
Sergio Bracarda
P2860
P356
10.1097/MD.0000000000002299
P407
P577
2016-01-01T00:00:00Z